Gregory Hooper

552 total citations
14 papers, 325 citations indexed

About

Gregory Hooper is a scholar working on Biotechnology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Gregory Hooper has authored 14 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biotechnology, 3 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Gregory Hooper's work include Marine Sponges and Natural Products (7 papers), Microbial Natural Products and Biosynthesis (3 papers) and Synthetic Organic Chemistry Methods (2 papers). Gregory Hooper is often cited by papers focused on Marine Sponges and Natural Products (7 papers), Microbial Natural Products and Biosynthesis (3 papers) and Synthetic Organic Chemistry Methods (2 papers). Gregory Hooper collaborates with scholars based in United Kingdom, United States and Switzerland. Gregory Hooper's co-authors include Michael T. Davies‐Coleman, William H. Gerwick, Randall C. Schatzman, Jimmy Orjala, Michelle Kelly‐Borges, Yi‐Long Wu, Saulius Cicėnas, Michael H. Schleyer, Fan Xia and Petar Petrov and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and Tetrahedron.

In The Last Decade

Gregory Hooper

12 papers receiving 306 citations

Peers

Countries citing papers authored by Gregory Hooper

Since Specialization

Citations

This map shows the geographic impact of Gregory Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Hooper more than expected).

Fields of papers citing papers by Gregory Hooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Hooper. The network helps show where Gregory Hooper may publish in the future.

Co-authorship network of co-authors of Gregory Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Hooper. A scholar is included among the top collaborators of Gregory Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Hooper. Gregory Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib 2020 ·Annals of Oncology ·Paolo A. Ascierto, Karl D. Lewis, Anna Maria Di Giacomo, Lev Demidov, Mario Mandalà, Igor Bondarenko, (unknown), Andrzej Maćkiewicz, Piotr Rutkowski, Alexander Guminski, Brian Simmons, (unknown), Gregory Hooper, Matthew Wongchenko, Grant R. Goodman, Y. Yan, Dirk Schadendorf	29
2	A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington’s disease 2019 ·Journal of the Neurological Sciences ·Blair R. Leavitt, Sarah J. Tabrizi, Patricia Sanwald Ducray, Edward J. Wild, (unknown), Gregory Hooper, (unknown), (unknown), (unknown), Roger Lane, Frank Bennett, Lauren Boak, Rachelle S. Doody, Scott Schobel	1
3	The Roche HD natural history study – An external comparator by design 2019 ·Journal of the Neurological Sciences ·Gregory Hooper, Giuseppe Palermo, (unknown), (unknown), (unknown), Lauren Boak, Rachelle S. Doody, Scott Schobel, Blair R. Leavitt	0
4	Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies 2018 ·Lung Cancer ·Yi‐Long Wu, Victor Lee, Chong Kin Liam, Shun Lü, Keunchil Park, Vichien Srimuninnimit, Jie Wang, Caicun Zhou, (unknown), Peter Button, Gregory Hooper, John F. Palma, Katja Schulze, Sidney Scudder, David S. Shames, (unknown), Guili Zhang, Tony Mok	35
5	Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study) 2016 ·Lung Cancer ·Saulius Cicėnas, Sarayut Lucien Geater, Petar Petrov, Yevhen Hotko, Gregory Hooper, Fan Xia, (unknown), Yi‐Long Wu	38
6	Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α‐2a (40KD) (PEGASYS^®) plus ribavirin (COPEGUS^®) for 16 or 24 weeks 2009 ·Liver International ·M. Rodríguez‐Torres, Sugantha Govindarajan, M. Diago, T. N. Morgan, Bhupinderjit S. Anand, Karl Barange, (unknown), Amy Lin, Gregory Hooper, Mitchell L. Shiffman	12
7	797 EASY TO ASSESS ON-TREATMENT PARAMETERS CORRELATE WITH DEGREE OF VIROLOGICAL RESPONSE AFTER 12 WEEKS OF TREATMENT 2008 ·Journal of Hepatology ·Dorte Møller Jensen, B. Freilich, Pietro Andreoné, A DIBISCEGLIE, Carlos Eduardo Brandão, K. Rajender Reddy, Antonio Craxı̀, Antonio Olveira, G Teuber, Diethelm Messinger, Gregory Hooper, (unknown), Andreas Tietz, Patrick Marcellin	2
8	Carmabins A and B, New Lipopeptides from the Caribbean Cyanobacterium Lyngbya majuscula 1998 ·Journal of Natural Products ·Gregory Hooper, Jimmy Orjala, Randall C. Schatzman, William H. Gerwick	68
9	New Diterpenes from the South African Soft Coral Eleutherobia aurea 1997 ·Journal of Natural Products ·Gregory Hooper, Michael T. Davies‐Coleman, Michael H. Schleyer	14
10	Biologically active natural products from South African marine invertebrates 1997 ·Gregory Hooper	1
11	New alkaloids from a South African latrunculid sponge 1996 ·Tetrahedron Letters ·Gregory Hooper, Michael T. Davies‐Coleman, Michelle Kelly‐Borges, (unknown)	58
12	New Metabolites from the South African soft coral Capnella thyrsoidea 1995 ·Tetrahedron ·Gregory Hooper, Michael T. Davies‐Coleman	37
13	New Antimicrobial C₁₄and C₁₃Amines from a South African Marine Ascidian 1995 ·Natural product letters ·Gregory Hooper, Michael T. Davies‐Coleman, (unknown)	10
14	Sesquiterpene hydroquinones from the South African soft coral Alcyonium fauri 1995 ·Tetrahedron Letters ·Gregory Hooper, Michael T. Davies‐Coleman	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact